Li, Meihui
Wang, Xinyuan
Gong, Jiali
Lu, Hongyang
Funding for this research was provided by:
Beijing Science and Technology Innovation Medical Development Foundation (KC2021-JX-0186-58)
Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China (No. LHDMY22H160003)
Article History
Received: 12 October 2024
Accepted: 12 December 2024
First Online: 9 January 2025
Declarations
:
: The protocol was approved by the Medical Ethics Committee of Zhejiang Cancer Hospital (IRB-2022–399). As the patient specimens were collected in a retrospective approach and some of the patients were deceased, exempt written informed consent was also approved by the Medical Ethics Committee of Zhejiang Cancer Hospital.
: The authors declare no competing interests.